You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GVHD prophylaxis

Showing 1 - 25 of 3,754
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

Not yet recruiting
  • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
  • Ruxolitinib 5 MG BID Oral Tablet
  • (no location specified)
Jun 13, 2023

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Lymphoma, Leukemia Trial (Acalabrutinib, tacrolimus, methotrexate)

Withdrawn
  • Lymphoma
  • Leukemia
  • Acalabrutinib, tacrolimus, methotrexate
  • (no location specified)
Feb 20, 2022

Cytomegalovirus Infection After HSCT and PT-CY as GVHD

Completed
  • CMV Infection
    • Malaga, Spain
      Maria Jesus Pascual
    Mar 30, 2022

    Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)

    Recruiting
    • Acute Leukemia
    • +3 more
    • VIC- 1911
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Aplastic Anemia Trial in Suzhou (CD20 mAb, ATG)

    Recruiting
    • Aplastic Anemia
    • CD20 monoclonal antibody
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Aug 21, 2022

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Center
    Apr 4, 2022

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

    Recruiting
    • Myeloid Malignancies
    • GvHD prophylaxis
    • Alessandria, Italy
    • +32 more
    Nov 23, 2022

    Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

    Recruiting
    • Graft-versus-host-disease
    • Relapse
    • Treatment Arm - high dose ATG
    • Control Arm - standard of care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    Oct 14, 2022

    Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

    Completed
    • Leukemia
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Sep 16, 2021

    GVHD Trial in Shenzhen, Shanghai (PTCY)

    Not yet recruiting
    • GVHD
    • Shenzhen, GaungDong, China
    • +1 more
    Aug 17, 2023

    GVHD Trial in Nantes (drug, radiation, other)

    Terminated
    • Graft Versus Host Disease
    • Nantes, France
      Nantes Uh
    Jul 13, 2022

    Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

    Terminated
    Has Results
    • Immunodeficiency
    • Infusion of donor lymphocytes
    • Charlotte, North Carolina
      Levine Children's Hospital, Carolinas Medical Center
    Apr 20, 2022

    Cytomegalovirus Infections Trial (Cytotect®CP)

    Recruiting
    • Cytomegalovirus Infections
    • Lille, France
      Hop Claude Huriez Chu Lille
    Nov 8, 2022

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Immunosuppression Only Conditioning
    • +3 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Graft Vs Host Disease, Hematopoietic Tumor Trial in Brazil (Methotrexate Injectable Solution)

    Recruiting
    • Graft Vs Host Disease
    • Hematopoietic Neoplasm
    • Methotrexate Injectable Solution
    • Rio De Janeiro, RJ, Brazil
    • +3 more
    Sep 10, 2021